Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (221-230 of 282) with videos related to

Pageof 29
Sort By:
JCO Global Oncology|July 18, 2020
Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery ImplementationRebecca J DeBoer, Cyprien Shyirambere, Caitlin D Driscoll, et al.
JAMA Oncology|September 24, 2020
Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With CancerChristopher R Manz, Jinbo Chen, Manqing Liu, et al.
Surgery|August 31, 2019
Barriers to timely surgery for breast cancer in RwandaLauren E Schleimer, Jean-Marie Vianney Dusengimana, John Butonzi, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Journal of Global Oncology|September 23, 2018
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in RwandaFidel Rubagumya, Mary Jue Xu, Leana May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapyHarold J Burstein, Yu-Hui Chen, Leroy M Parker, et al.
The Oncologist|March 25, 2016
Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral CenterLydia E Pace, Jean-Marie V Dusengimana, Vedaste Hategekimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 1997
Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodesJ S Wong, A Recht, C J Beard, et al.
Journal of Global Oncology|November 28, 2019
Cluster Randomized Trial to Facilitate Breast Cancer Early Diagnosis in a Rural District of RwandaLydia E Pace, Jean Marie Vianney Dusengimana, Lawrence N Shulman, et al.
Pageof 29

Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
JCO Global Oncology|July 18, 2020
Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery ImplementationRebecca J DeBoer, Cyprien Shyirambere, Caitlin D Driscoll, et al.
JAMA Oncology|September 24, 2020
Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With CancerChristopher R Manz, Jinbo Chen, Manqing Liu, et al.
Surgery|August 31, 2019
Barriers to timely surgery for breast cancer in RwandaLauren E Schleimer, Jean-Marie Vianney Dusengimana, John Butonzi, et al.
JCO Oncology Practice|May 27, 2020
Management of Lung Cancer During the COVID-19 PandemicAditi P Singh, Abigail T Berman, Melina E Marmarelis, et al.
Journal of Global Oncology|September 23, 2018
Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in RwandaFidel Rubagumya, Mary Jue Xu, Leana May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapyHarold J Burstein, Yu-Hui Chen, Leroy M Parker, et al.
The Oncologist|March 25, 2016
Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral CenterLydia E Pace, Jean-Marie V Dusengimana, Vedaste Hategekimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 1997
Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodesJ S Wong, A Recht, C J Beard, et al.
Journal of Global Oncology|November 28, 2019
Cluster Randomized Trial to Facilitate Breast Cancer Early Diagnosis in a Rural District of RwandaLydia E Pace, Jean Marie Vianney Dusengimana, Lawrence N Shulman, et al.
Pageof 29